Increasing prevalence of cardiovascular diseases will help global hypertension drugs market reach $32 billion by 2020
This market research report presents a detailed segmentation of the global hypertension drugs market by type (systemic hypertension drugs and pulmonary hypertension drugs) and by geography (Americas, APAC, and EMEA). The key vendors in the market are Novartis, Daiichi Sankyo, Actelion Pharmaceuticals, Boehringer Ingelheim, Sanofi, and AstraZeneca. Technavio’s market research analysts estimate the global…